← All organizations
Highest phase reached
Phase 4
First clinical trial
Nov 1, 2007Last known activity
Nov 1, 2025
Timeline
1960s
- Jan 1, 1962
University of Jordan— Founded
Drugs by trial phase (48 distinct, 55 trials)
Phase 4 (12 own, 0 via acquisition)
Phase 3 (7 own, 0 via acquisition)
Phase 2 (8 own, 0 via acquisition)
Phase 1 (7 own, 0 via acquisition)
Other trials (14 own, 0 via acquisition)
Indications
Studied for
- Arrhythmias, Cardiac
- Bone Cysts
- Bone Cysts, Aneurysmal
- Cartilage Diseases
- Cysts
- Diabetes Mellitus
- Diabetes Mellitus, Type 1
- Diabetes Mellitus, Type 2
- Diabetic Foot
- Diabetic Nephropathies
- Erectile Dysfunction
- Foot Ulcer
- Hypospadias
- Hypotension
- Inflammatory Bowel Diseases
- Intestinal Diseases
- Ischemia
- Kidney Diseases
- Multiple Sclerosis
- Nausea
- Osteoarthritis
- Osteoarthritis, Knee
- Parkinson Disease
- Peripheral Arterial Disease
- Peripheral Vascular Diseases
- Pharyngitis
- Postoperative Nausea and Vomiting
- Postoperative Pain
- Sclerosis
- Spinal Cord Injuries
- Ulcer
- Vitamin D Deficiency
- Vomiting
- Wounds and Injuries
Recent trials (50)
- NCT07310485Sponsor investigatorN/ANov 1, 2025
- NCT07310485Lead sponsorN/ANov 1, 2025
- NCT07280520Sponsor investigatorN/ANov 1, 2025
- NCT07280520Lead sponsorN/ANov 1, 2025
- NCT06894069Lead sponsorEarly Phase 1Mar 31, 2025
- NCT06894069Sponsor investigatorEarly Phase 1Mar 31, 2025
- NCT06587880Sponsor investigatorPhase 4Jan 2, 2025
- NCT06587880Lead sponsorPhase 4Jan 2, 2025
- NCT06827665CollaboratorPhase 1/Phase 2Jan 1, 2025
- NCT06825884Sponsor investigatorPhase 1Dec 1, 2024
- NCT06825884Lead sponsorPhase 1Dec 1, 2024
- NCT06937528Sponsor investigatorPhase 1Jan 1, 2024
- NCT06937528CollaboratorPhase 1Jan 1, 2024
- NCT06937528Lead sponsorPhase 1Jan 1, 2024
- NCT06103188Reponsible party - principal investigatorPhase 3Oct 2, 2023
Details
- Founded
- Amman, JO Jan 1, 1962
- Last known activity
- Nov 1, 2025